scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PLoSO...3.3445M |
P356 | DOI | 10.1371/JOURNAL.PONE.0003445 |
P932 | PMC publication ID | 2563688 |
P698 | PubMed publication ID | 18941502 |
P5875 | ResearchGate publication ID | 23403296 |
P50 | author | Céline Méhats | Q55875767 |
P2093 | author name string | Thomas Schmitz | |
Christophe Delacourt | |||
Danièle Evain-Brion | |||
Olivier Boucherat | |||
Pierre-Henri Jarreau | |||
Emmanuel Lopez | |||
Marie-Laure Franco-Montoya | |||
Elodie Zana | |||
Jacques Bourbon | |||
P2860 | cites work | Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. | Q44524786 |
Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury | Q44945408 | ||
Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain | Q46080598 | ||
Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study | Q47175290 | ||
Outcome of extremely low birth weight infants with leukemoid reaction | Q47379843 | ||
Upregulation of phosphodiesterase-4 in the lung of allergic rats | Q47861309 | ||
Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress | Q48024586 | ||
Characterization of cyclic nucleotide phosphodiesterases of rat tissues | Q48824116 | ||
Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. | Q51685958 | ||
Rapid onset of gene expression in lung, supportive of formation of alveolar septa, induced by refeeding mice after calorie restriction. | Q53576295 | ||
PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation. | Q54449137 | ||
Effect of intratracheal adenoviral vector administration on lung development in newborn rats | Q64378371 | ||
Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst | Q68160262 | ||
The postnatal development and growth of the human lung. I. Morphometry | Q69003350 | ||
The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats | Q71203407 | ||
Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site | Q72335344 | ||
Pentoxifylline does not protect against hyperoxic lung injury in rats | Q72798459 | ||
Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats | Q73286382 | ||
Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats | Q77741773 | ||
Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils | Q77933655 | ||
Investigation of the molecular mechanisms preceding PDE4 inhibitor-induced vasculopathy in rats: tissue inhibitor of metalloproteinase 1, a potential predictive biomarker | Q80479749 | ||
Nitric oxide donor restores lung growth factor and receptor expression in hyperoxia-exposed rat pups | Q82582862 | ||
Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis | Q24817140 | ||
The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram | Q28115926 | ||
Bronchopulmonary dysplasia | Q28237555 | ||
Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use | Q28263273 | ||
Gene expression profiling in lung fibroblasts reveals new players in alveolarization | Q28569682 | ||
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice | Q28594618 | ||
Role of osteopontin in cellular signaling and toxicant injury | Q28594622 | ||
Caffeine Therapy for Apnea of Prematurity | Q29395883 | ||
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses | Q30732295 | ||
Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia | Q34446393 | ||
Postnatal development of alveoli. Regulation and evidence for a critical period in rats | Q34557173 | ||
Long-term effects of caffeine therapy for apnea of prematurity | Q34711652 | ||
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury | Q34727917 | ||
Bronchopulmonary dysplasia-oxidative stress and antioxidants | Q35095604 | ||
Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease. | Q35592380 | ||
An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease | Q35827644 | ||
Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia | Q36092140 | ||
The radial alveolar count method of Emery and Mithal: a reappraisal 1--postnatal lung growth | Q36122596 | ||
The radial alveolar count method of Emery and Mithal: a reappraisal 2--intrauterine and early postnatal lung growth | Q36122656 | ||
Contribution of inflammation to lung injury and development | Q36403068 | ||
Are phosphodiesterase 4 inhibitors just more theophylline? | Q36496374 | ||
Chronic lung disease after premature birth. | Q36995880 | ||
4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain | Q40035136 | ||
Phosphodiesterase isozymes: molecular targets for novel antiasthma agents | Q41708863 | ||
Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia | Q41886471 | ||
The postnatal growth of the rat lung. I. Morphometry | Q43589639 | ||
Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats | Q43660336 | ||
Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3',5'-monophosphate-dependent pathway | Q44238617 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e3445 | |
P577 | publication date | 2008-10-20 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats | |
P478 | volume | 3 |
Q35168732 | Caffeine and rolipram affect Smad signalling and TGF-β1 stimulated CTGF and transgelin expression in lung epithelial cells |
Q96124116 | Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19 |
Q36767721 | Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation |
Q28579991 | Differential expression of cyclic nucleotide phosphodiesterases 4 in developing rat lung |
Q27303463 | Effect of two models of intrauterine growth restriction on alveolarization in rat lungs: morphometric and gene expression analysis |
Q43863162 | Inflammation and bronchopulmonary dysplasia |
Q35950168 | Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. |
Q92610839 | Rolipram Protects Mice from Gram-negative Bacterium Escherichia coli-induced Inflammation and Septic Shock |
Search more.